Trials / Completed
CompletedNCT02663739
Zenith® TXD Post-market Surveillance in Japan
Zenith TXD Dissection Stent Graft System Usage Results Surveillance in Japan for Treating Acute Complicated Stanford Type B Aortic Dissection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 57 (actual)
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is a post-market surveillance study required by Japanese Regulatory Authorities as a condition of approval
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith® TXD | Zenith® TXD Dissection Stent Graft System for treatment of patients with aortic dissection of the descending thoracic aorta |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2023-03-28
- Completion
- 2023-03-28
- First posted
- 2016-01-26
- Last updated
- 2023-06-07
Locations
27 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02663739. Inclusion in this directory is not an endorsement.